BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

被引:6
|
作者
Lopez-Munoz, Eunice [1 ]
Hernandez-Zarco, Adelina [1 ]
Garcia-Hernandez, Normand [1 ]
Alvarado-Cabrero, Isabel [2 ]
Zarco-Espinosa, Gelasio [3 ]
Salamanca-Gomez, Fabio
Arenas-Aranda, Diego [1 ]
机构
[1] Hosp Pediat Mexico City, Unidad Invest Med Genet Humana, Ctr Med Nacl Siglo XXI CMN S XXI, Inst Mexicano Seguro Social IMSS, Mexico City 06720, DF, Mexico
[2] Hosp Oncol, Serv Patol, CMN SXXI, IMSS, Mexico City 06720, DF, Mexico
[3] Hosp Oncol, Serv Tumores Mama, CMN S XXI, IMSS, Mexico City 06720, DF, Mexico
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2012年 / 14卷 / 08期
关键词
BIK/NBK; Estrogen receptor; Breast cancer; ENDOPLASMIC-RETICULUM BIK; BCL-2 PROTEIN FAMILY; CELL-DEATH; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITORS; AROMATASE INHIBITORS; BH3-ONLY PROTEIN; DRUG-RESISTANCE;
D O I
10.1007/s12094-012-0845-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study is to determine the association between the BIK/NBK gene expression and estrogen receptor alpha expression. We determined the association of BIK/NBK gene expression by real time quantitative reverse transcription polymerase chain reaction and estrogen receptor alpha expression by immunohistochemistry in samples of breast cancer tissue. We found a statistically significant correlation of BIK/NBK gene expression with the estrogen receptor alpha expression (rho = 0.751, p = 0.004). For verify differences of BIK/NBK gene expression among ER alpha+ and ER alpha- breast cancer tissues, Mann-Whitney U test was performed, obtaining significant differences. BIK/NBK gene expression may have important clinical implications and provide predictive, prognostic or therapeutic marker in breast cancer patients according to the estrogen receptor alpha expression.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [31] Erratum to: BAK, BAX, and NBK/BIK Proapoptotic Gene Alterations in Iranian Patients with Ataxia Telangiectasia
    Anna Isaian
    Natalia V. Bogdanova
    Masoud Houshmand
    Masoud Movahadi
    Asghar Aghamohammadi
    Nima Rezaei
    Lida Atarod
    Mahnaz Sadeghi-Shabestari
    Seyed Hasan Tonekaboni
    Zahra Chavoshzadeh
    Seyed Mohammad Seyed Hassani
    Reza Mirfakhrai
    Taher Cheraghi
    Najmoddin Kalantari
    Mitra Ataei
    Thilo Dork-Bousset
    Mohammad Hossein Sanati
    Journal of Clinical Immunology, 2010, 30 : 620 - 620
  • [32] Notch-4 is a novel therapeutic target and prognostic marker for triple negative breast cancer
    Kai, M.
    Mori, H.
    Yamada, M.
    Kubo, M.
    Nakamura, M.
    BREAST, 2017, 32 : S96 - S96
  • [33] Mammaglobin A as a diagnostic marker and therapeutic target in breast cancer
    Lisiak, Natalia
    Sierszulska, Maria
    Bajsert, Julia
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 566 - 571
  • [34] RAD51AP1 is a novel prognostic marker and therapeutic target for breast cancer
    Thangaraju, M.
    Kolhe, R. B.
    Pathania, R.
    CANCER RESEARCH, 2017, 77
  • [35] Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
    Deborah Ryan
    Steven Carberry
    Áine C. Murphy
    Andreas U. Lindner
    Joanna Fay
    Suzanne Hector
    Niamh McCawley
    Orna Bacon
    Caoimhin G. Concannon
    Elaine W. Kay
    Deborah A. McNamara
    Jochen H. M. Prehn
    Journal of Translational Medicine, 14
  • [36] Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
    Nathaniel Melling
    Johanna Muth
    Ronald Simon
    Carsten Bokemeyer
    Luigi Terracciano
    Guido Sauter
    Jakob Robert Izbicki
    Andreas Holger Marx
    Diagnostic Pathology, 10
  • [37] Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
    Ryan, Deborah
    Carberry, Steven
    Murphy, Aine C.
    Lindner, Andreas U.
    Fay, Joanna
    Hector, Suzanne
    McCawley, Niamh
    Bacon, Orna
    Concannon, Caoimhin G.
    Kay, Elaine W.
    McNamara, Deborah A.
    Prehn, Jochen H. M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [38] Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer
    Theriault, Brigitte L.
    Pajovic, Sanja
    Bernardini, Marcus Q.
    Shaw, Patricia A.
    Gallie, Brenda L.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (08) : 1844 - 1854
  • [39] The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer
    Bahrami, Afsane
    Hassanian, Seyed Mahdi
    Khazaei, Majid
    Gharib, Masoumeh
    Rahmani, Mahsa
    Fiuji, Hamid
    Jazayeri, Mir Hadi
    Moetamani-Ahmadi, Mehrdad
    Ferns, Gordon A.
    Avan, Amir
    PHARMACOGENOMICS, 2018, 19 (05) : 463 - 474
  • [40] Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
    Melling, Nathaniel
    Muth, Johanna
    Simon, Ronald
    Bokemeyer, Carsten
    Terracciano, Luigi
    Sauter, Guido
    Izbicki, Jakob Robert
    Marx, Andreas Holger
    DIAGNOSTIC PATHOLOGY, 2015, 10